Mb. Stokes et al., IMMUNE-COMPLEX GLOMERULONEPHRITIS IN PATIENTS COINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS AND HEPATITIS-C VIRUS, American journal of kidney diseases, 29(4), 1997, pp. 514-525
Human immunodeficiency virus-associated nephropathy (HIVAN), character
ized by heavy proteinuria, rapidly progressive renal failure, ''collap
sing'' glomerulopathy, and tubulointerstitial abnormalities, is the mo
st common finding in HIV-infected patients undergoing a renal biopsy a
nd predominantly affects blacks. We describe the clinical features and
renal pathologic findings of 12 intravenous drug users (IVDUs) coinfe
cted with HIV and hepatitis C virus (HCV) who were selected for renal
biopsy because they presented with features different from typical HIV
AN, including hypertension, microscopic hematuria, and cryoglobulinemi
a, There were seven black and five Hispanic patients. Eleven patients
had immune complex glomerulonephritis (ICGN); one had glomeruloscleros
is with immune complex deposits. Ten individuals had evidence of past
hepatitis B viral infection, but none had persistent hepatitis B surfa
ce antigenemia. No other underlying cause for immune complex glomerulo
nephritis was identified. Renal biopsy showed membranoproliferative gl
omerulonephritis in five patients, mesangial proliferative glomerulone
phritis in five, membranous nephropathy in one, and ''collapsing'' glo
merulopathy with immune complex deposits in one. Hepatitis C virus RNA
was detected by reverse transcription-polymerase chain reaction (RT-P
CR) in the renal tissue and/or serum of nine of the 11 patients tested
, and also in the renal biopsy tissue of four of eight patients with c
linical and pathologic features of typical HIVAN without immunofluores
cence evidence of immune complex deposits. One patient presented with
renal failure, five patients developed end-stage renal disease (ESRD)
requiring hemodialysis (mean time, 6.5 months), and six had stable ren
al function after a mean follow-up of 29.1 months (range, 2 to 72 mont
hs). Liver function abnormalities were present in seven of the 12 indi
viduals, including four of the six patients who developed renal failur
e. These findings indicate that in some patients coinfected with HIV a
nd HCV, the development of ICGN may dominate the clinical course of th
e disease. The occurrence of ICGN among black patients at risk for HIV
AN may be related to the relatively high prevalence of HCV infection a
mong IVDUs in this group. (C) 1997 by the National Kidney Foundation,
Inc.